CONTACT US

© 2026 Delmarva Public Media
A service of Salisbury University and University of Maryland Eastern Shore
Give Now
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Support Provided By: (Sponsored Content)

What's the latest with the Trump admin's promise on lower drug prices in Medicaid?

NPR | By Sydney Lupkin,
Scott Detrow
Published September 14, 2026 at 4:34 PM EDT

The Trump admin's drug price deals came with a promise to offer lower prices in Medicaid. But the goalposts keep moving. Instead of all drugs, it's just one or two. And the deadlines for states to voluntarily sign on has been pushed back twice. So what's the status?

Copyright 2026 NPR
Sydney Lupkin
Sydney Lupkin is the pharmaceuticals correspondent for NPR, where she has reported on accelerated drug approvals whose confirmatory trials were overdue, Operation Warp Speed contract accountability, and the ripple effects of obesity drug shortages. 
See stories by Sydney Lupkin
Scott Detrow
Scott Detrow is a host of All Things Considered, as well as NPR’s daily news podcast Consider This.
See stories by Scott Detrow
Local news is powered by listeners like you
Help us continue our comprehensive coverage of the Delmarva Peninsula and the mentoring of the broadcasters and journalists of tomorrow by becoming a sustaining member of Delmarva Public Media
Become a Program Partner